한글목차

일본의 디지털 헬스 시장은 2024년에 109억 6,000만 달러, 2033년에는 5,142만 달러에 달할 것으로 예측되며, 2025년부터 2033년까지 예측 기간 동안 19.0%의 연평균 복합 성장률(CAGR)을 보일 것으로 예상됩니다.

디지털 헬스(Digital Health)는 디지털 기술을 활용하여 의료 서비스를 개선하고, 건강 결과를 개선하며, 환자의 전반적인 웰빙을 증진시키는 것을 의미합니다. 이 급성장 분야는 모바일 앱, 웨어러블, 인공지능(AI), 원격의료, 전자건강기록(EMR)(EHR)과 같은 기술을 의료의 다양한 측면에 통합합니다. 그 목적은 의료 서비스의 효율성, 접근성, 품질을 향상시키고, 의료 서비스를 보다 개인화, 적시성, 효과성을 향상시키는 것입니다.

디지털 헬스 솔루션은 다양한 의료 서비스 제공업체 간의 더 나은 진료 협업을 촉진하고, 환자 경험을 개선하며, 단편적인 진료를 줄입니다. 기술이 계속 발전함에 따라 디지털 건강은 의료 서비스 제공 방식을 더욱 혁신하여 보다 접근성이 높고, 효율적이며, 환자 중심의 서비스를 제공할 것으로 기대됩니다.

시장 역학:

성장 촉진요인과 억제요인

노령인구 증가

일본의 고령화는 디지털 헬스 시장의 주요 촉진요인으로, 만성질환 유병률 증가와 장기요양 필요성으로 인해 의료서비스에 대한 수요가 증가하고 있습니다. 원격 의료, 원격 모니터링, 웨어러블, AI 기반 도구와 같은 디지털 헬스 솔루션은 노인들이 원격으로 진료에 접근하고, 중요한 건강 지표를 실시간으로 추적하고, 만성 질환을 보다 효과적으로 관리할 수 있도록 함으로써 이러한 문제를 해결하는 데 필수적입니다.

이러한 기술은 개인화된 치료를 제공할 뿐만 아니라, 특히 전문 인력이 부족한 지방에서는 의료 제공업체의 부담을 덜어줍니다. 또한, 보조 로봇이나 스마트 홈 솔루션과 같은 혁신은 노인들의 일상생활을 개선하고 있습니다. '의료 정책 2025'와 같은 이니셔티브를 통한 정부의 지원으로 디지털 헬스 솔루션은 일본 의료 시스템에 점점 더 통합되고 있으며, 노인들이 필요한 치료를 받을 수 있도록 하는 동시에 전체 의료의 효율성과 접근성을 향상시키고 있습니다.

기술적 한계

기술적 한계는 몇 가지 측면에서 일본의 디지털 헬스 시장의 성장을 크게 저해할 것으로 예상됩니다. 일본은 강력한 기술 인프라를 보유하고 있음에도 불구하고, 의료 시스템 간의 상호 운용성이 부족하고, 소프트웨어가 구식이며, 데이터 포맷이 표준화되지 않은 등의 문제로 인해 디지털 헬스 솔루션의 원활한 통합을 제한할 수 있습니다.

제1장 분석 방법과 분석 범위

제2장 정의와 개요

제3장 주요 요약

제4장 시장 역학

• 영향요인
  • 성장 촉진요인
  • 성장 억제요인
  • 기회
• 영향 분석

제5장 전략적 통찰과 업계 전망

• 시장 리더와 선구자
  • 새로운 선구자와 주요 기업
  • 최대 판매를 자랑하는 브랜드를 확립한 리더
  • 확립된 제품을 가지는 시장 리더
• CXO 시점
• 최신 개발과 Break through
• 사례 연구/진행 중인 연구
• 규제와 상환 상황
• Porter의 산업 분석
• 공급망 분석
• 특허 분석
• SWOT 분석
• 미충족 요구와 갭
• 시장 참여로 확대를 위한 추천 전략
• 시나리오 분석 : 베스트 케이스/베이스 케이스/워스트 케이스 예측
• 가격 분석과 가격 시장 역학
• 키 업계 리더 (KOL)

제6장 구성요소별

• 하드웨어
• 소프트웨어
• 서비스

제7장 종류별

• 모바일 헬스
• e-health
• 텔레헬스(원격의료)
• 건강 분석
• 기타

제8장 최종사용자별

• 의료 제공자
• 의료 소비자
• 기타

제9장 경쟁 구도

• 경쟁 시나리오
• 시장 현황 및 점유율 분석
• M&A분석

제10장 기업 개요

• OMRON Corporation
  • 기업 개요
  • 제품 포트폴리오
    • 제품 설명
    • 제품 핵심성과지표(KPI)
    • 제품 판매 실적과 예측
  • 재무 개요
    • 기업 매출
    • 매출 점유율 : 지역별
    • 매출 예측
  • 주요 동향
    • 인수합병(M&A)
    • 주요 제품 개발 활동
    • 규제기관 승인 등
  • SWOT 분석
• CureApp
• Shionogi & Co., Ltd.
• HealthNode
• Whill
• Allm Inc.
• Dai-ichi Life Holdings, Inc.
• Xiaomi
• Hitachi Energy Ltd.
• Similar data will be provided for each market player.

제11장 부록

영문목차

The Japan digital health market reached US$ 10.96 billion in 2024 and is expected to reach US$ 51.42 million by 2033, growing at a CAGR of 19.0% during the forecast period of 2025-2033.

Digital health refers to using digital technologies to improve healthcare delivery, enhance health outcomes, and promote a patient's overall well-being. This rapidly growing field integrates technology such as mobile apps, wearables, artificial intelligence (AI), telemedicine, and electronic health records (EHRs) into various aspects of healthcare. The objective is to enhance the efficiency, accessibility, and quality of care, making healthcare services more personalized, timely, and effective.

Digital health solutions facilitate better coordination of care across various healthcare providers, improving patient experiences and reducing fragmented care. As technology continues to evolve, digital health is expected to further revolutionize how healthcare is delivered, offering more accessible, efficient, and patient-centered services.

Market Dynamics: Drivers & Restraints

Rising Geriatric Population

Japan's aging population is a key driver of the digital health market, as the demand for healthcare services increases due to the higher prevalence of chronic diseases and the need for long-term care. Digital health solutions, such as telemedicine, remote monitoring, wearables, and AI-driven tools, are essential in addressing these challenges by enabling elderly individuals to access care remotely, track vital health metrics in real time, and manage chronic conditions more effectively.

These technologies not only provide personalized care but also reduce the burden on healthcare providers, particularly in rural areas where there is a shortage of professionals. Additionally, innovations like assistive robots and smart home solutions are improving the daily lives of elderly people. With government support through initiatives like the "Healthcare Policy 2025," digital health solutions are increasingly integrated into Japan's healthcare system, ensuring that elderly citizens can receive the care they need while improving overall healthcare efficiency and accessibility.

Technical Limitations

Technical limitations are expected to significantly hinder the growth of Japan's digital health market in several ways. Despite Japan's strong technological infrastructure, challenges such as insufficient interoperability between healthcare systems, outdated software, and lack of standardized data formats can limit the seamless integration of digital health solutions.

Segment Analysis

The Japan digital health market is segmented based on component, type, and end-user.

Type:

mHealth in the type segment is expected to dominate in the Japan digital health market.

Japan has a high smartphone penetration rate and a tech-savvy population, making mobile health applications and services highly accessible and widely adopted. The aging population, in particular, is a major driver for mHealth solutions, as mobile apps and wearables can help older adults monitor their health, track vital signs, and manage chronic conditions without requiring frequent visits to healthcare providers.

mHealth solutions, such as health tracking apps, medication reminders, and telemedicine platforms, offer convenience and flexibility for patients, empowering them to take charge of their health. Moreover, Japan's focus on preventative care and wellness aligns with the growing use of mHealth tools that promote healthier lifestyles, encourage regular physical activity, and track diet and sleep. As more healthcare providers and patients embrace mobile solutions for daily health management, the mHealth segment is expected to lead Japan's digital health market growth by offering efficient, accessible, and personalized healthcare options.

Competitive Landscape

The major players in Japan digital health market include Takeda Pharmaceutical Company Limited, OMRON Corporation, CureApp, Shionogi & Co., Ltd., HealthNode, Whill, Allm Inc., Dai-ichi Life Holdings, Inc., Xiaomi, and Hitachi Energy Ltd., among others.

Why Purchase the Report?

• Pipeline & Innovations: Reviews ongoing clinical trials and product pipelines and forecasts upcoming advancements in medical devices and pharmaceuticals.
• Product Performance & Market Positioning: Analyze product performance, market positioning, and growth potential to optimize strategies.
• Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
• Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
• Market Updates & Industry Changes: This covers recent regulatory changes, new policies, and emerging technologies.
• Competitive Strategies: Analyze competitor strategies, market share, and emerging players.
• Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
• Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
• Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
• Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
• Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
• Post-market Surveillance: Uses post-market data to enhance product safety and access.
• Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The Japan Digital Health Market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

• Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
• Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
• Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
• Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
• Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
• Supply Chain: Distribution and Supply Chain Managers.
• Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
• Academic & Research: Academic Institutions.

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

• 3.1. Snippet by Component
• 3.2. Snippet by Type
• 3.3. Snippet by End-User

4. Dynamics

• 4.1. Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. Rising Geriatric Population
    • 4.1.1.2. Increasing Adoption of Advanced Technologies in Home Healthcare
  • 4.1.2. Restraints
    • 4.1.2.1. Technical Limitations
    • 4.1.2.2. Data Privacy Concerns
  • 4.1.3. Opportunity
    • 4.1.3.1. Increasing Strategic Initiatives by Market Players
• 4.2. Impact Analysis

5. Strategic Insights and Industry Outlook

• 5.1. Market Leaders and Pioneers
  • 5.1.1. Emerging Pioneers and Prominent Players
  • 5.1.2. Established leaders with largest selling Brand
  • 5.1.3. Market leaders with established Product
• 5.2. CXO Perspectives
• 5.3. Latest Developments and Breakthroughs
• 5.4. Case Studies/Ongoing Research
• 5.5. Regulatory and Reimbursement Landscape
• 5.6. Porter's Five Forces Analysis
• 5.7. Supply Chain Analysis
• 5.8. Patent Analysis
• 5.9. SWOT Analysis
• 5.10. Unmet Needs and Gaps
• 5.11. Recommended Strategies for Market Entry and Expansion
• 5.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
• 5.13. Pricing Analysis and Price Dynamics
• 5.14. Key Opinion Leaders

6. By Component

• 6.1. Introduction
  • 6.1.1. Analysis and Y-o-Y Growth Analysis (%), By Component
  • 6.1.2. Market Attractiveness Index, By Component
• 6.2. Hardware*
  • 6.2.1. Introduction
  • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 6.3. Software
• 6.4. Services

7. By Type

• 7.1. Introduction
  • 7.1.1. Analysis and Y-o-Y Growth Analysis (%), By Type
  • 7.1.2. Market Attractiveness Index, By Type
• 7.2. mHealth*
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 7.3. eHealth
• 7.4. Telehealthcare
• 7.5. Health Analytics
• 7.6. Others

8. By End-User

• 8.1. Introduction
  • 8.1.1. Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 8.1.2. Market Attractiveness Index, By End-User
• 8.2. Healthcare Providers*
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 8.3. Healthcare Consumers
• 8.4. Others

9. Competitive Landscape

• 9.1. Competitive Scenario
• 9.2. Market Positioning/Share Analysis
• 9.3. Mergers and Acquisitions Analysis

10. Company Profiles

Key Market Players

• 10.1. OMRON Corporation*
  • 10.1.1. Company Overview
  • 10.1.2. Product Portfolio
    • 10.1.2.1. Product Description
    • 10.1.2.2. Product Key Performance Indicators (KPIs)
    • 10.1.2.3. Historic and Forecasted Product Sales
  • 10.1.3. Financial Overview
    • 10.1.3.1. Company Revenue's
    • 10.1.3.2. Geographical Revenue Shares
    • 10.1.3.3. Revenue Forecasts
  • 10.1.4. Key Developments
    • 10.1.4.1. Mergers & Acquisitions
    • 10.1.4.2. Key Product Development Activities
    • 10.1.4.3. Regulatory Approvals, etc.
  • 10.1.5. SWOT Analysis
• 10.2. CureApp
• 10.3. Shionogi & Co., Ltd.
• 10.4. HealthNode
• 10.5. Whill
• 10.6. Allm Inc.
• 10.7. Dai-ichi Life Holdings, Inc.
• 10.8. Xiaomi
• 10.9. Hitachi Energy Ltd.
• Similar data will be provided for each market player.

LIST NOT EXHAUSTIVE

11. Appendix

• 11.1. About Us and Services
• 11.2. Contact Us